Akumin announces US $35M bought deal
Akumin (TSX: AKU.U) engaged Clarus Securities Inc. for a bought deal of 8,750,000 Common Shares at US $4.00 for gross proceeds of US $35,000,000
Healthcare & Life Sciences
DiaMedica Therapeutics closes US $2.5M final tranche of private placemet
DiaMedica Therapeutics (TSX-V: DMA; OTCQB: DMCAF) closed second and final tranche of offering for gross proceeds of approximately US$2.5M. The company raised US $6.3M in two tranches.
Xenon Pharmaceuticals closes Teva and BVF transactions
Xenon Pharmaceuticals (NASDAQ: XENE) terminated collaborative development and license agreement with Teva Pharmaceuticals and closed share exchange transaction with Biotechnology Value Fund (BVF)
Profound Medical completes $34.5M bought deal
Profound Medical Corp. (TSX-V: PRN; OTCQX: PRFMF) closed previously announced bought for gross proceeds of $34.5M. Canaccord Genuity Corp. led the offering
Cognetivity Neurosciences trades on CSE
Cognetivity Neurosciences Ltd. (CSE: CGN) commenced trading on the Canadian Securities Exchange (CSE) under the ticker symbol “CGN”.
HLS Therapeutics and Automodular closes RTO merger
HLS Therapeutics Inc. and Automodular Corporation completed RTO transaction
Immunovaccine announces $12.M bought deal led byEchelon Wealth Partners
Immunovaccine Inc. (TSX: IMV; OTCQX: IMMVF) engaged Echelon Wealth Partners Inc. for a bought deal financing of 6,250,000 common shares at $2.00 per share for gross proceeds of $12.5 million
Nova Leap Health announces $2M brokered private placement
NOVA LEAP HEALTH CORP. (TSX-V: NLH) engaged Haywood Securities Inc. for a best efforts private placement of units at $0.25 for gross proceeds of a minimum of $1.25M and maximum of $2M
Pacgen Life Science closes $738K private placement
Pacgen Life Science Corporation (TSX-V: PBS) completed a non-brokered private placement of 12,300,000 units at $0.06 per unit for gross proceeds of $738,000.
Aequus Pharmaceuticals announces $300K private placement
Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) intends to complete a non-brokered private placement of 1,000,000 units at a price of $0.30 per unit for gross proceeds of $300,000
